Zacks: Outpatient Stocks Have an Edge

In a post from a Zacks Investment Research blog, the firm is supporting outpatient facility stock.

In light of both the Veterans Affairs scheduling scandal and recent articles confirming the much lower costs of outpatient treatment while attaining similar or higher levels of patient satisfaction than hospitals, the analysts note: "It is clear from these factors that outpatient clinics or surgical centers can fill a crucial gap in the healthcare system. On one hand, they can cater to the large numbers of patients whom hospitals are unable to cater to. At the same time, they offer several procedures at lower costs, making them cost effective options for patients."

The post also promoted AmSurg Corp. as a stock with a "good Zacks rank," potential to grow in the current healthcare environment and as a "good addition to your portfolio.

More Articles on Turnarounds:
5 Tips for Keeping Meeting Momentum
Medline Enters Orthopedic Foot and Ankle Market
7 Things for ASC Leaders to Know for Monday

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months